Big Money Exits: Iconic Pharma Stock Sold by High-Profile Asset Manager

On October 21, 2025, Generali Asset Management disclosed a sale of 6,430 Eli Lilly and Company (NYSE:LLY) shares, an estimated $4.78 million trade based on the average quarterly price in Q3 2025.According to a filing with the Securities and Exchange Commission dated October 21, 2025, Generali Asset Management reduced its stake in Eli Lilly and Company by 6,430 shares. The estimated trade value, based on the average closing price for the period, was approximately $4.78 million. The position now stands at 61,292 shares.This was a sale; the post-trade stake represents 1.0% of the fund’s 13F reportable assets under management.Continue readingWeiter zum vollständigen Artikel bei MotleyFool Weiter zum vollständigen Artikel bei MotleyFool